Astigmatism Correction With Intrastromal Arcuate Incisions in Eyes Undergoing Cataract Surgery With Femtosecond Laser Using the Cassini Ambient With Iris Registration (ARCUATAS)

Sponsor
OFTALVIST (Oftalmología Vistahermosa S.L) (Industry)
Overall Status
Recruiting
CT.gov ID
NCT05053620
Collaborator
Johnson & Johnson Surgical Vision, Inc. (Industry)
33
1
8.7
3.8

Study Details

Study Description

Brief Summary

This is an observational, prospective follow-up post-marketing study of CE marked medical devices aimed at treating astigmatism in patients with cataracts. The main objective is to evaluate the response of the intrastromal arcuate incisions procedure for the correction of low corneal astigmatism with the Catalys femtosecond laser using the Cassini Ambient equipment with iris registration in cataract surgery.

Condition or Disease Intervention/Treatment Phase
  • Device: Calculation of the arcuate intrasomal incisions

Detailed Description

All patients participating in the study will undergo femtosecond laser treatment for the correction of astigmatism through arcuate intrastromal incisions with the Catalys laser (Johnson & Johnson, USA, CE marked). The calculation of intrastromal arcuate incisions will be carried out using the following nomogram indicated on the laser: 9.0 mm optical zone and symmetrical incisions of 50 degrees for 0.50D, 55 degrees for 0.75D, 60 degrees for 1.00D and 65 degrees for 1.25D of corneal astigmatism. After the incisions, conventional cataract surgery will be performed using the Centurion phacoemulsifier equipment (Alcon, USA, with CE marking) in the ZCB00 monofocal intraocular lens (IOL) implant (Johnson & Johnson, USA, with CE marking). All patients will be treated according to standard clinical practice.

A preoperative and postoperative evaluation will be carried out one month and four months after the intervention where the following tests will be performed: refraction, corneal topography with the Cassini Ambient equipment (Cassini Technologies, The Netherlands, with CE marking), measurement of visual acuity with and without correction, slit lamp examination and ocular biometry using the IOLMaster 700 non-contact optical biometer (Carl Zeiss, Germany, CE marked).

Study Design

Study Type:
Observational
Anticipated Enrollment :
33 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Astigmatism Correction With Intrastromal Arcuate Incisions in Eyes Undergoing Cataract Surgery With Femtosecond Laser Using the Cassini Ambient With Iris Registration (ARCUATAS)
Actual Study Start Date :
Aug 9, 2021
Anticipated Primary Completion Date :
Mar 31, 2022
Anticipated Study Completion Date :
Apr 30, 2022

Arms and Interventions

Arm Intervention/Treatment
Single arm

All patients.

Device: Calculation of the arcuate intrasomal incisions
All patients participating in the study will undergo femtosecond laser treatment for the correction of astigmatism through arcuate intrastromal incisions with the Catalys laser (Johnson & Johnson, USA, CE marked). The calculation of intrastromal arcuate incisions will be carried out using the following nomogram indicated on the laser: 9.0 mm optical zone and symmetrical incisions of 50 degrees for 0.50D, 55 degrees for 0.75D, 60 degrees for 1.00D and 65 degrees for 1.25D of corneal astigmatism. After the incisions, conventional cataract surgery will be performed using the Centurion phacoemulsifier equipment (Alcon, USA, with CE marking) in the ZCB00 monofocal intraocular lens (IOL) implant (Johnson & Johnson, USA, with CE marking). All patients will be treated according to standard clinical practice.

Outcome Measures

Primary Outcome Measures

  1. Response to treatment [4 months after the procedure]

    Evaluation of the response to the procedure

Secondary Outcome Measures

  1. Evaluation of the visual acuity [4 months after the procedure]

    Evaluation of the visual acuity

  2. Examination of the arcuate incisions [4 months after the procedure]

    Examination of the arcuate incisions using a slit amp

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Patients who are going to undergo cataract surgery.

  2. Low corneal astigmatism, between 0.50D and 1.25D.

Exclusion Criteria:
  1. Previous corneal surgery.

  2. Keratoconus.

  3. Corneal scars

  4. Pterygium

  5. Glaucoma

Contacts and Locations

Locations

Site City State Country Postal Code
1 OFTALVIST (Oftalmología Vistahermosa S.L.) Alicante Spain 03015

Sponsors and Collaborators

  • OFTALVIST (Oftalmología Vistahermosa S.L)
  • Johnson & Johnson Surgical Vision, Inc.

Investigators

  • Principal Investigator: Pedro Tañá Rivero, Doctor, OFTALVIST (Oftalmología Vistahermosa S.L)

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
OFTALVIST (Oftalmología Vistahermosa S.L)
ClinicalTrials.gov Identifier:
NCT05053620
Other Study ID Numbers:
  • ARCUATAS
First Posted:
Sep 22, 2021
Last Update Posted:
Feb 4, 2022
Last Verified:
Oct 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 4, 2022